HEADER NUCLEOTIDYLTRANSFERASE 17-AUG-98 1BQN TITLE TYR 188 LEU HIV-1 RT/HBY 097 COMPND MOL_ID: 1; COMPND 2 MOLECULE: REVERSE TRANSCRIPTASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HIV-1 RT; COMPND 5 EC: 2.7.7.49; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: REVERSE TRANSCRIPTASE; COMPND 10 CHAIN: B; COMPND 11 SYNONYM: HIV-1 RT; COMPND 12 EC: 2.7.7.49; COMPND 13 ENGINEERED: YES; COMPND 14 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 STRAIN: BH10; SOURCE 5 CELL_LINE: 293; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: 293; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 11 ORGANISM_TAXID: 11676; SOURCE 12 STRAIN: BH10; SOURCE 13 CELL_LINE: 293; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: 293 KEYWDS NUCLEOTIDYLTRANSFERASE, AIDS, RNA-DIRECTED DNA POLYMERASE, HIV-1 KEYWDS 2 RT/HBY 097, DRUG-RESISTANT MUTANT EXPDTA X-RAY DIFFRACTION AUTHOR Y.HSIOU,K.DAS,J.DING,E.ARNOLD REVDAT 7 22-MAY-24 1BQN 1 REMARK REVDAT 6 09-AUG-23 1BQN 1 REMARK REVDAT 5 03-NOV-21 1BQN 1 REMARK SEQADV REVDAT 4 24-FEB-09 1BQN 1 VERSN REVDAT 3 01-APR-03 1BQN 1 JRNL REVDAT 2 16-FEB-99 1BQN 3 HET COMPND REMARK HETATM REVDAT 2 2 3 DBREF JRNL REVDAT 1 06-JAN-99 1BQN 0 JRNL AUTH Y.HSIOU,K.DAS,J.DING,A.D.CLARK JR.,J.P.KLEIM,M.ROSNER, JRNL AUTH 2 I.WINKLER,G.RIESS,S.H.HUGHES,E.ARNOLD JRNL TITL STRUCTURES OF TYR188LEU MUTANT AND WILD-TYPE HIV-1 REVERSE JRNL TITL 2 TRANSCRIPTASE COMPLEXED WITH THE NON-NUCLEOSIDE INHIBITOR JRNL TITL 3 HBY 097: INHIBITOR FLEXIBILITY IS A USEFUL DESIGN FEATURE JRNL TITL 4 FOR REDUCING DRUG RESISTANCE. JRNL REF J.MOL.BIOL. V. 284 313 1998 JRNL REFN ISSN 0022-2836 JRNL PMID 9813120 JRNL DOI 10.1006/JMBI.1998.2171 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH K.DAS,J.DING,Y.HSIOU,A.D.CLARK JUNIOR,H.MOEREELS,L.KOYMANS, REMARK 1 AUTH 2 K.ANDRIES,R.PAUWELS,P.A.JANSSEN,P.L.BOYER,P.CLARK, REMARK 1 AUTH 3 R.H.SMITH JUNIOR,M.B.KROEGER SMITH,C.J.MICHEJDA,S.H.HUGHES, REMARK 1 AUTH 4 E.ARNOLD REMARK 1 TITL CRYSTAL STRUCTURES OF 8-CL AND 9-CL TIBO COMPLEXED WITH REMARK 1 TITL 2 WILD-TYPE HIV-1 RT AND 8-CL TIBO COMPLEXED WITH THE REMARK 1 TITL 3 TYR181CYS HIV-1 RT DRUG-RESISTANT MUTANT REMARK 1 REF J.MOL.BIOL. V. 264 1085 1996 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 2 REMARK 1 AUTH E.ARNOLD,K.DAS,J.DING,P.N.YADAV,Y.HSIOU,P.L.BOYER,S.H.HUGHES REMARK 1 TITL TARGETING HIV REVERSE TRANSCRIPTASE FOR ANTI-AIDS DRUG REMARK 1 TITL 2 DESIGN: STRUCTURAL AND BIOLOGICAL CONSIDERATIONS FOR REMARK 1 TITL 3 CHEMOTHERAPEUTIC STRATEGIES REMARK 1 REF DRUG DES.DISCOVERY V. 13 29 1996 REMARK 1 REFN ISSN 1055-9612 REMARK 1 REFERENCE 3 REMARK 1 AUTH Y.HSIOU,J.DING,K.DAS,A.D.CLARK JUNIOR,S.H.HUGHES,E.ARNOLD REMARK 1 TITL STRUCTURE OF UNLIGANDED HIV-1 REVERSE TRANSCRIPTASE AT 2.7 A REMARK 1 TITL 2 RESOLUTION: IMPLICATIONS OF CONFORMATIONAL CHANGES FOR REMARK 1 TITL 3 POLYMERIZATION AND INHIBITION MECHANISMS REMARK 1 REF STRUCTURE V. 4 853 1996 REMARK 1 REFN ISSN 0969-2126 REMARK 1 REFERENCE 4 REMARK 1 AUTH J.DING,K.DAS,C.TANTILLO,W.ZHANG,A.D.CLARK JUNIOR,S.JESSEN, REMARK 1 AUTH 2 X.LU,Y.HSIOU,A.JACOBO-MOLINA,K.ANDRIES,R.PAUWELS,H.MOEREELS, REMARK 1 AUTH 3 L.KOYMANS,P.A.J.JANSSEN,R.H.SMITH JUNIOR,M.KROEGER KOEPKE, REMARK 1 AUTH 4 C.J.MICHEJDA,S.H.HUGHES,E.ARNOLD REMARK 1 TITL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN A COMPLEX WITH REMARK 1 TITL 2 THE NON-NUCLEOSIDE INHIBITOR ALPHA-APA R 95845 AT 2.8 A REMARK 1 TITL 3 RESOLUTION REMARK 1 REF STRUCTURE V. 3 365 1995 REMARK 1 REFN ISSN 0969-2126 REMARK 1 REFERENCE 5 REMARK 1 AUTH J.DING,K.DAS,H.MOEREELS,L.KOYMANS,K.ANDRIES,P.A.JANSSEN, REMARK 1 AUTH 2 S.H.HUGHES,E.ARNOLD REMARK 1 TITL STRUCTURE OF HIV-1 RT/TIBO R 86183 COMPLEX REVEALS REMARK 1 TITL 2 SIMILARITY IN THE BINDING OF DIVERSE NONNUCLEOSIDE REMARK 1 TITL 3 INHIBITORS REMARK 1 REF NAT.STRUCT.BIOL. V. 2 407 1995 REMARK 1 REFN ISSN 1072-8368 REMARK 1 REFERENCE 6 REMARK 1 AUTH C.TANTILLO,J.DING,A.JACOBO-MOLINA,R.G.NANNI,P.L.BOYER, REMARK 1 AUTH 2 S.H.HUGHES,R.PAUWELS,K.ANDRIES,P.A.JANSSEN,E.ARNOLD REMARK 1 TITL LOCATIONS OF ANTI-AIDS DRUG BINDING SITES AND RESISTANCE REMARK 1 TITL 2 MUTATIONS IN THE THREE-DIMENSIONAL STRUCTURE OF HIV-1 REMARK 1 TITL 3 REVERSE TRANSCRIPTASE. IMPLICATIONS FOR MECHANISMS OF DRUG REMARK 1 TITL 4 INHIBITION AND RESISTANCE REMARK 1 REF J.MOL.BIOL. V. 243 369 1994 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 7 REMARK 1 AUTH A.JACOBO-MOLINA,J.DING,R.G.NANNI,A.D.CLARK JUNIOR,X.LU, REMARK 1 AUTH 2 C.TANTILLO,R.L.WILLIAMS,G.KAMER,A.L.FERRIS,P.CLARK,A.HIZI, REMARK 1 AUTH 3 S.H.HUGHES,E.ARNOLD REMARK 1 TITL CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REMARK 1 TITL 2 REVERSE TRANSCRIPTASE COMPLEXED WITH DOUBLE-STRANDED DNA AT REMARK 1 TITL 3 3.0 A RESOLUTION SHOWS BENT DNA REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 90 6320 1993 REMARK 1 REFN ISSN 0027-8424 REMARK 2 REMARK 2 RESOLUTION. 3.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.85 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 10.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.1 REMARK 3 NUMBER OF REFLECTIONS : 18523 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.245 REMARK 3 FREE R VALUE : 0.362 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1758 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.44 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 85.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1736 REMARK 3 BIN R VALUE (WORKING SET) : 0.3320 REMARK 3 BIN FREE R VALUE : 0.4160 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 93 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7812 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 22 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 79.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 48.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.61 REMARK 3 ESD FROM SIGMAA (A) : 0.71 REMARK 3 LOW RESOLUTION CUTOFF (A) : 10.0 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.73 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.78 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.017 REMARK 3 BOND ANGLES (DEGREES) : 2.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 2.040 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARAM19X.PRO REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 PARAMETER FILE 3 : PARHCSDX.PRO REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1BQN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000172007. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : MAR-96 REMARK 200 TEMPERATURE (KELVIN) : 108 REMARK 200 PH : 6.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CHESS REMARK 200 BEAMLINE : F1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.918 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : WIGGLERS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : PRINCETON 2K REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29728 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 2.900 REMARK 200 R MERGE (I) : 0.10300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.1400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.08 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.1 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : 0.90000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR 3.85 REMARK 200 STARTING MODEL: PDB ENTRY 1TVR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.45 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 6.8 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 112.40000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.65000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 112.40000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 34.65000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5390 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 48770 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -26.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TRP A 24 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 24 CZ3 CH2 REMARK 470 LEU A 26 CG CD1 CD2 REMARK 470 THR A 27 OG1 CG2 REMARK 470 ILE A 63 CG1 CG2 CD1 REMARK 470 LYS A 64 CG CD CE NZ REMARK 470 LYS A 66 CG CD CE NZ REMARK 470 ASP A 67 CG OD1 OD2 REMARK 470 LYS A 70 CG CD CE NZ REMARK 470 GLN A 91 CG CD OE1 NE2 REMARK 470 GLU A 138 CG CD OE1 OE2 REMARK 470 THR A 139 OG1 CG2 REMARK 470 LEU A 188 CG CD1 CD2 REMARK 470 LYS A 219 CG CD CE NZ REMARK 470 LYS A 220 CG CD CE NZ REMARK 470 GLN A 222 CG CD OE1 NE2 REMARK 470 GLU A 224 CG CD OE1 OE2 REMARK 470 GLU A 233 CG CD OE1 OE2 REMARK 470 ARG A 277 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 284 CG CD NE CZ NH1 NH2 REMARK 470 THR A 286 OG1 CG2 REMARK 470 LYS A 287 CG CD CE NZ REMARK 470 LEU A 289 CG CD1 CD2 REMARK 470 VAL A 292 CG1 CG2 REMARK 470 ILE A 293 CG1 CG2 CD1 REMARK 470 GLU A 297 CG CD OE1 OE2 REMARK 470 LEU A 301 CG CD1 CD2 REMARK 470 LYS A 311 CG CD CE NZ REMARK 470 LYS A 323 CG CD CE NZ REMARK 470 GLU A 328 CG CD OE1 OE2 REMARK 470 GLN A 334 CG CD OE1 NE2 REMARK 470 GLN A 336 CG CD OE1 NE2 REMARK 470 LYS A 347 CG CD CE NZ REMARK 470 ARG A 356 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 366 CG CD CE NZ REMARK 470 ILE A 411 CG1 CG2 CD1 REMARK 470 LYS A 424 CG CD CE NZ REMARK 470 ASN A 447 CG OD1 ND2 REMARK 470 GLU A 529 CG CD OE1 OE2 REMARK 470 ASP A 549 CG OD1 OD2 REMARK 470 LYS A 550 CG CD CE NZ REMARK 470 ILE A 556 CG1 CG2 CD1 REMARK 470 ARG A 557 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 558 CG CD CE NZ REMARK 470 LYS B 13 CG CD CE NZ REMARK 470 LYS B 66 CG CD CE NZ REMARK 470 LYS B 70 CG CD CE NZ REMARK 470 ASP B 121 CG OD1 OD2 REMARK 470 GLN B 174 CG CD OE1 NE2 REMARK 470 LYS B 220 CG CD CE NZ REMARK 470 HIS B 221 CG ND1 CD2 CE1 NE2 REMARK 470 GLN B 222 CG CD OE1 NE2 REMARK 470 TRP B 229 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP B 229 CZ3 CH2 REMARK 470 MET B 230 CG SD CE REMARK 470 ASP B 237 CG OD1 OD2 REMARK 470 GLU B 248 CG CD OE1 OE2 REMARK 470 LYS B 249 CG CD CE NZ REMARK 470 ASP B 250 CG OD1 OD2 REMARK 470 LYS B 281 CG CD CE NZ REMARK 470 LEU B 283 CG CD1 CD2 REMARK 470 ARG B 284 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 305 CG CD OE1 OE2 REMARK 470 LEU B 310 CG CD1 CD2 REMARK 470 GLU B 312 CG CD OE1 OE2 REMARK 470 LYS B 323 CG CD CE NZ REMARK 470 MET B 357 CG SD CE REMARK 470 HIS B 361 CG ND1 CD2 CE1 NE2 REMARK 470 LEU B 422 CG CD1 CD2 REMARK 470 TYR B 427 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLN B 428 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 514 CG GLU A 514 CD 0.091 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 9 C - N - CA ANGL. DEV. = 16.8 DEGREES REMARK 500 PRO A 9 C - N - CD ANGL. DEV. = -13.7 DEGREES REMARK 500 PRO A 55 C - N - CA ANGL. DEV. = 10.2 DEGREES REMARK 500 PRO A 217 C - N - CA ANGL. DEV. = 14.9 DEGREES REMARK 500 PRO A 217 C - N - CD ANGL. DEV. = -14.2 DEGREES REMARK 500 PRO A 225 C - N - CA ANGL. DEV. = 16.6 DEGREES REMARK 500 PRO A 225 N - CA - C ANGL. DEV. = 20.2 DEGREES REMARK 500 PRO A 313 C - N - CA ANGL. DEV. = 12.8 DEGREES REMARK 500 PRO A 321 C - N - CA ANGL. DEV. = 12.2 DEGREES REMARK 500 PRO A 392 C - N - CA ANGL. DEV. = 9.5 DEGREES REMARK 500 PRO A 537 C - N - CA ANGL. DEV. = 10.6 DEGREES REMARK 500 LYS B 64 N - CA - C ANGL. DEV. = -17.6 DEGREES REMARK 500 ILE B 94 N - CA - C ANGL. DEV. = -18.0 DEGREES REMARK 500 PRO B 176 C - N - CA ANGL. DEV. = 10.9 DEGREES REMARK 500 THR B 215 N - CA - C ANGL. DEV. = -19.1 DEGREES REMARK 500 GLY B 316 N - CA - C ANGL. DEV. = -28.2 DEGREES REMARK 500 PRO B 345 C - N - CA ANGL. DEV. = 13.3 DEGREES REMARK 500 PRO B 387 C - N - CA ANGL. DEV. = 10.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 4 52.04 -118.91 REMARK 500 GLU A 6 106.54 -52.79 REMARK 500 PRO A 14 132.74 -36.42 REMARK 500 LYS A 22 117.89 -160.16 REMARK 500 ILE A 50 -164.88 -119.59 REMARK 500 GLU A 53 -9.34 -51.35 REMARK 500 ALA A 62 57.31 -116.79 REMARK 500 ILE A 63 179.08 -55.43 REMARK 500 LYS A 64 76.44 -161.06 REMARK 500 ASP A 67 38.70 106.26 REMARK 500 GLN A 91 75.70 -64.96 REMARK 500 LEU A 92 42.08 -101.37 REMARK 500 LYS A 104 -73.70 -7.03 REMARK 500 ASP A 113 48.31 -93.25 REMARK 500 ARG A 125 -35.78 -38.72 REMARK 500 THR A 128 25.72 -72.76 REMARK 500 ILE A 132 74.92 -110.80 REMARK 500 ASN A 136 40.15 -92.78 REMARK 500 ASN A 137 32.47 28.77 REMARK 500 GLN A 145 -147.71 -95.12 REMARK 500 LEU A 149 103.39 -58.41 REMARK 500 PRO A 150 171.61 -59.17 REMARK 500 TRP A 153 92.89 0.25 REMARK 500 LYS A 154 -57.43 -4.15 REMARK 500 SER A 156 -73.28 -29.15 REMARK 500 MET A 184 -94.53 44.77 REMARK 500 GLU A 194 106.17 -57.28 REMARK 500 ILE A 195 -63.78 23.80 REMARK 500 THR A 200 -71.73 -54.08 REMARK 500 THR A 216 75.10 -150.36 REMARK 500 PRO A 217 -10.72 -41.94 REMARK 500 ASP A 218 -39.18 -29.66 REMARK 500 LYS A 219 -174.15 76.29 REMARK 500 LYS A 220 73.62 -35.11 REMARK 500 HIS A 221 -23.72 77.25 REMARK 500 GLN A 222 -149.27 75.66 REMARK 500 PRO A 225 -46.64 -3.17 REMARK 500 LEU A 228 49.25 -83.62 REMARK 500 MET A 230 59.94 35.44 REMARK 500 PRO A 236 -15.30 -37.91 REMARK 500 THR A 240 -163.07 173.19 REMARK 500 GLN A 242 -98.76 -118.11 REMARK 500 PRO A 243 99.25 -51.39 REMARK 500 PRO A 247 -151.24 -93.63 REMARK 500 SER A 251 88.40 -171.63 REMARK 500 ILE A 270 -72.09 -95.58 REMARK 500 TYR A 271 107.17 -49.67 REMARK 500 ARG A 277 -92.45 -4.33 REMARK 500 ARG A 284 -47.40 -21.25 REMARK 500 THR A 286 42.91 -60.09 REMARK 500 REMARK 500 THIS ENTRY HAS 154 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A 319 0.08 SIDE CHAIN REMARK 500 TYR B 183 0.08 SIDE CHAIN REMARK 500 PHE B 346 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 GLY B 316 -10.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HBY A 559 DBREF 1BQN A 1 558 UNP P03366 POL_HV1B1 599 1156 DBREF 1BQN B 1 430 UNP P03366 POL_HV1B1 599 1028 SEQADV 1BQN LEU A 188 UNP P03366 TYR 355 ENGINEERED MUTATION SEQADV 1BQN GLN A 248 UNP P03366 GLU 415 CONFLICT SEQADV 1BQN SER A 280 UNP P03366 CYS 447 ENGINEERED MUTATION SEQADV 1BQN GLN A 546 UNP P03366 GLU 713 CONFLICT SEQADV 1BQN LEU B 188 UNP P03366 TYR 355 ENGINEERED MUTATION SEQADV 1BQN GLU B 242 UNP P03366 GLN 409 CONFLICT SEQADV 1BQN ALA B 278 UNP P03366 GLN 445 CONFLICT SEQADV 1BQN SER B 280 UNP P03366 CYS 447 ENGINEERED MUTATION SEQRES 1 A 558 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 A 558 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 A 558 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 A 558 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 A 558 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 A 558 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 A 558 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 A 558 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SEQRES 9 A 558 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 A 558 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 A 558 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 A 558 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 A 558 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 A 558 PRO PHE LYS LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 A 558 TYR MET ASP ASP LEU LEU VAL GLY SER ASP LEU GLU ILE SEQRES 16 A 558 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 A 558 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 A 558 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 A 558 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 A 558 GLN LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 A 558 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 A 558 ILE LYS VAL ARG GLN LEU SER LYS LEU LEU ARG GLY THR SEQRES 23 A 558 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 A 558 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 A 558 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 A 558 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 A 558 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 A 558 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 A 558 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 A 558 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 A 558 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 A 558 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 A 558 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU SEQRES 34 A 558 GLU LYS GLU PRO ILE VAL GLY ALA GLU THR PHE TYR VAL SEQRES 35 A 558 ASP GLY ALA ALA ASN ARG GLU THR LYS LEU GLY LYS ALA SEQRES 36 A 558 GLY TYR VAL THR ASN LYS GLY ARG GLN LYS VAL VAL PRO SEQRES 37 A 558 LEU THR ASN THR THR ASN GLN LYS THR GLU LEU GLN ALA SEQRES 38 A 558 ILE TYR LEU ALA LEU GLN ASP SER GLY LEU GLU VAL ASN SEQRES 39 A 558 ILE VAL THR ASP SER GLN TYR ALA LEU GLY ILE ILE GLN SEQRES 40 A 558 ALA GLN PRO ASP LYS SER GLU SER GLU LEU VAL ASN GLN SEQRES 41 A 558 ILE ILE GLU GLN LEU ILE LYS LYS GLU LYS VAL TYR LEU SEQRES 42 A 558 ALA TRP VAL PRO ALA HIS LYS GLY ILE GLY GLY ASN GLN SEQRES 43 A 558 GLN VAL ASP LYS LEU VAL SER ALA GLY ILE ARG LYS SEQRES 1 B 430 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 B 430 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 B 430 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 B 430 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 B 430 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 B 430 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 B 430 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 B 430 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SEQRES 9 B 430 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 B 430 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 B 430 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 B 430 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 B 430 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 B 430 PRO PHE LYS LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 B 430 TYR MET ASP ASP LEU LEU VAL GLY SER ASP LEU GLU ILE SEQRES 16 B 430 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 B 430 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 B 430 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 B 430 HIS PRO ASP LYS TRP THR VAL GLU PRO ILE VAL LEU PRO SEQRES 20 B 430 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 B 430 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 B 430 ILE LYS VAL ARG ALA LEU SER LYS LEU LEU ARG GLY THR SEQRES 23 B 430 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 B 430 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 B 430 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 B 430 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 B 430 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 B 430 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 B 430 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 B 430 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 B 430 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 B 430 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 B 430 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU SEQRES 34 B 430 GLU HET HBY A 559 22 HETNAM HBY (S)-4-ISOPROPOXYCARBONYL-6-METHOXY-3-METHYLTHIOMETHYL- HETNAM 2 HBY 3,4-DIHYDROQUINOXALIN-2(1H)-THIONE HETSYN HBY HBY 097 FORMUL 3 HBY C15 H20 N2 O3 S2 HELIX 1 AA GLU A 28 GLU A 44 1 17 HELIX 2 AB ARG A 78 ARG A 83 1 6 HELIX 3 AC ALA A 114 SER A 117 1 4 HELIX 4 AD GLU A 122 TYR A 127 1 6 HELIX 5 AE LYS A 154 GLN A 174 1 21 HELIX 6 AF ILE A 195 TRP A 212 1 18 HELIX 7 AH VAL A 254 GLN A 269 1 16 HELIX 8 AI ARG A 277 LEU A 283 1 7 HELIX 9 AJ GLU A 297 LYS A 311 1 15 HELIX 10 AK ASP A 364 TRP A 383 1 20 HELIX 11 AL LYS A 395 GLU A 404 1 10 HELIX 12 A' ASN A 474 ASP A 488 1 15 HELIX 13 B' GLN A 500 ALA A 508 1 9 HELIX 14 D' GLU A 516 LYS A 527 1 12 HELIX 15 E' GLY A 544 ALA A 554 1 11 HELIX 16 BA GLU B 28 GLU B 44 1 17 HELIX 17 BB ARG B 78 VAL B 90 1 13 HELIX 18 BC GLY B 112 SER B 117 1 6 HELIX 19 BD GLU B 122 THR B 128 1 7 HELIX 20 BE LYS B 154 GLN B 174 1 21 HELIX 21 BF ILE B 195 TRP B 212 1 18 HELIX 22 BH VAL B 254 ILE B 270 1 17 HELIX 23 BI ARG B 277 LEU B 283 1 7 HELIX 24 BJ GLU B 297 LYS B 311 1 15 HELIX 25 BK ASP B 364 TRP B 383 1 20 HELIX 26 BL LYS B 395 TYR B 405 1 11 SHEET 1 S1 3 ILE A 47 ILE A 50 0 SHEET 2 S1 3 ILE A 142 TYR A 146 -1 SHEET 3 S1 3 THR A 128 ILE A 132 -1 SHEET 1 S2 2 ASN A 57 LYS A 64 0 SHEET 2 S2 2 ARG A 72 PHE A 77 -1 SHEET 1 S3 3 SER A 105 VAL A 111 0 SHEET 2 S3 3 ASP A 186 SER A 191 -1 SHEET 3 S3 3 ILE A 178 TYR A 183 -1 SHEET 1 S4 4 PHE A 227 TRP A 229 0 SHEET 2 S4 4 TYR A 232 HIS A 235 -1 SHEET 3 S4 4 LYS A 238 VAL A 241 -1 SHEET 4 S4 4 VAL A 314 ASP A 320 -1 SHEET 1 S5 5 LYS A 347 ARG A 356 0 SHEET 2 S5 5 GLN A 336 TYR A 342 -1 SHEET 3 S5 5 LEU A 325 GLN A 332 -1 SHEET 4 S5 5 PRO A 387 LEU A 391 1 SHEET 5 S5 5 GLU A 413 THR A 419 1 SHEET 1 S6 5 GLY A 462 THR A 470 0 SHEET 2 S6 5 LEU A 452 THR A 459 -1 SHEET 3 S6 5 GLU A 438 ASN A 447 -1 SHEET 4 S6 5 GLU A 492 THR A 497 1 SHEET 5 S6 5 LYS A 530 VAL A 536 1 SHEET 1 S7 3 ILE B 47 GLY B 51 0 SHEET 2 S7 3 ILE B 142 TYR B 146 -1 SHEET 3 S7 3 ALA B 129 ILE B 132 -1 SHEET 1 S8 2 TYR B 56 LYS B 64 0 SHEET 2 S8 2 TRP B 71 ASP B 76 -1 SHEET 1 S9 3 SER B 105 ASP B 110 0 SHEET 2 S9 3 ASP B 186 SER B 191 -1 SHEET 3 S9 3 ILE B 178 TYR B 183 -1 SHEET 1 S10 5 LYS B 347 ARG B 356 0 SHEET 2 S10 5 GLN B 336 TYR B 342 -1 SHEET 3 S10 5 LEU B 325 LYS B 331 -1 SHEET 4 S10 5 PRO B 387 LEU B 391 1 SHEET 5 S10 5 GLU B 413 VAL B 417 1 SITE 1 AC1 13 LEU A 100 LYS A 101 VAL A 106 VAL A 179 SITE 2 AC1 13 TYR A 181 LEU A 188 VAL A 189 GLY A 190 SITE 3 AC1 13 TRP A 229 LEU A 234 HIS A 235 PRO A 236 SITE 4 AC1 13 TYR A 318 CRYST1 224.800 69.300 105.300 90.00 105.80 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004448 0.000000 0.001259 0.00000 SCALE2 0.000000 0.014430 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009870 0.00000